NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
211 Linköping |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 79 | 0.3% | 12 | 0.0% | . | . | 2 | 0.0% | . | . | . | . | 1 | 0.0% | 24120 | 99.6% | 24214 | 100.0% |
ASCUS | 63 | 5.7% | 168 | 15.3% | 1 | 0.1% | 125 | 11.4% | 3 | 0.3% | 2 | 0.2% | 3 | 0.3% | 733 | 66.8% | 1098 | 100.0% |
CIN1 | 34 | 6.8% | 153 | 30.7% | 1 | 0.2% | 90 | 18.0% | 3 | 0.6% | 5 | 1.0% | 6 | 1.2% | 207 | 41.5% | 499 | 100.0% |
Atypical glandular cells/AGC | 13 | 50.0% | 3 | 11.5% | . | . | 1 | 3.8% | 5 | 19.2% | . | . | . | . | 4 | 15.4% | 26 | 100.0% |
Unclear atypia | 1 | 100.0% | . | . | . | . | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% |
ASC-H | 3 | 4.4% | 16 | 23.5% | . | . | 43 | 63.2% | 4 | 5.9% | 1 | 1.5% | . | . | 1 | 1.5% | 68 | 100.0% |
CIN3 | 1 | 0.7% | 11 | 7.4% | . | . | 120 | 81.1% | 8 | 5.4% | 5 | 3.4% | 1 | 0.7% | 2 | 1.4% | 148 | 100.0% |
Adenocarcinoma | . | . | 1 | 9.1% | . | . | . | . | 5 | 45.5% | 4 | 36.4% | . | . | 1 | 9.1% | 11 | 100.0% |
Malignant tumor with unclear origin | . | . | . | . | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% | 1 | 100.0% |
Squamous cell cancer | . | . | . | . | . | . | 5 | 50.0% | . | . | 5 | 50.0% | . | . | . | . | 10 | 100.0% |
Total | 194 | 0.7% | 364 | 1.4% | 2 | 0.0% | 386 | 1.5% | 28 | 0.1% | 22 | 0.1% | 11 | 0.0% | 25069 | 96.1% | 26076 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81403 |